Company Filing History:
Years Active: 1989-1994
Title: Uwe Maetzel: Innovator in Pharmaceutical Chemistry
Introduction
Uwe Maetzel is a notable inventor based in Burgdorf, Germany, recognized for his contributions to pharmaceutical chemistry. With a total of four patents to his name, Maetzel has made significant advancements in the field, particularly in the development of novel chemical processes and compounds.
Latest Patents
Maetzel's latest patents include innovative formulations such as crystalline fumaric acid salts of 9,9-alkylene-3,7-diazabicyclononane - 1.5. He has also developed fumaric acid salts of N,N'-di-lower alkyl-substituted 9,9-alkylene-3,7-diazabicyclo[3.3.1]nonanes, along with a process for obtaining them in stoichiometrically pure and virtually non-hygroscopic form. Additionally, he has patented a process for preparing cis-dihydronopol, which involves stereoselectively hydrogenating corresponding esters of (-)nopol in the presence of specific catalysts.
Career Highlights
Uwe Maetzel is currently associated with Kali-Chemie Pharma GmbH, where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the company's portfolio but has also advanced the field of medicinal chemistry.
Collaborations
Maetzel has collaborated with esteemed colleagues such as Walter Heitmann and Uwe Schoen, further enhancing the impact of his research and inventions.
Conclusion
Uwe Maetzel's innovative work in pharmaceutical chemistry exemplifies the importance of research and development in creating effective medical solutions. His patents reflect a commitment to advancing the field and improving healthcare outcomes.